NCT06979947

Brief Summary

This study aims to evaluate the impact of a structured education program delivered under midwife guidance on menopause-specific quality of life among women aged 45-55 undergoing natural menopause, and to assess the sustainability of its effects over time.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
101

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2024

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2024

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 30, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

November 30, 2024

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

May 10, 2025

Completed
10 days until next milestone

First Posted

Study publicly available on registry

May 20, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

2 months

First QC Date

May 10, 2025

Last Update Submit

May 18, 2025

Conditions

Keywords

MenopauseStructured EducationMidwiferyMENQOLWomen's Health

Outcome Measures

Primary Outcomes (1)

  • Change in Menopause-Specific Quality of Life (MENQOL) Scores

    Mean change in total and subscale scores of the Menopause-Specific Quality of Life Questionnaire (MENQOL) from baseline to 6-month follow-up. Higher scores indicate greater symptom severity and lower quality of life.The MENQOL total score ranges from 0 to 6. Higher scores indicate greater symptom severity and lower quality of life.

    Baseline (T1), 4 weeks after intervention (T2), and 6 months after intervention (T3)

Secondary Outcomes (1)

  • Change in MENQOL Subscale Scores (Vasomotor, Psychosocial, Physical, Sexual)

    Baseline, 4 weeks, and 6 months

Study Arms (2)

Intervention Group

EXPERIMENTAL

Participants received a structured menopause education program delivered by a midwife. The program consisted of four weekly sessions, each lasting 20-25 minutes, covering menopause-related symptoms, physiological changes, and coping strategies. Educational materials were developed by the researchers and validated by experts. The education was tailored based on participants' MENQOL pre-test scores.

Behavioral: Structured Menopause Education Program

Control Group

NO INTERVENTION

Participants received no intervention during the study. They completed the same assessments at the same time points as the intervention group. After final data collection, the educational material was shared with them to ensure equity.

Interventions

The structured education program was developed by midwifery researchers and delivered face-to-face by a certified midwife over four weekly sessions. Each session lasted approximately 20-25 minutes and covered topics such as menopausal symptoms, lifestyle changes, and coping strategies. Educational materials were individualized based on participants' MENQOL pre-test scores.

Intervention Group

Eligibility Criteria

Age45 Years - 55 Years
Sexfemale
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • Women aged 45-55
  • Experiencing natural (non-surgical) menopause
  • Literate and able to complete questionnaires
  • No neurological or cognitive impairments
  • Willing to participate and attend sessions
  • Has access to phone/internet

You may not qualify if:

  • Surgical menopause
  • Hormonal disorders causing amenorrhea
  • Current use of hormonal therapy or antidepressants
  • Diagnosed psychiatric conditions
  • Removal Criteria (if applicable):
  • Did not attend at least 80% of sessions
  • Lost to follow-up at 6 months
  • Developed a new health issue affecting menopause
  • Participated in other menopause interventions
  • Incomplete or inconsistent questionnaire

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hasköy Family Health Center

Muş, CİTY, 49100, Turkey (Türkiye)

Location

Study Officials

  • KADER ATABEY

    Inonu University

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
The study was not blinded; both participants and investigators were aware of group assignments.
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Participants were assigned to either an intervention group receiving structured education or a control group receiving no intervention.
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 10, 2025

First Posted

May 20, 2025

Study Start

April 1, 2024

Primary Completion

May 30, 2024

Study Completion

November 30, 2024

Last Updated

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

There is no plan to share individual participant data (IPD).

Locations